Articles tagged with: Autologous Stem Cell Transplant

Opinion»

[ by | Aug 10, 2015 4:30 pm | 44 Comments ]
Pat’s Place: I’m Home!

It’s been 37 long, hard days away from home for my salvage transplant. The good news: I’m home early!

I left last week facing a very difficult decision: Should I take my specialist’s advice and move forward with a second, tandem, stem cell transplant?

My doctor felt if the first one didn’t work, well, skip the second transplant. But if the one I just had got most, or all, of my myeloma, crush it with a second transplant.

“Don’t make a decision now,” he told me and my wife Pattie at our …

Read the full story »

News»

[ by | May 29, 2015 11:52 pm | 2 Comments ]
Latest Myeloma Research To Be Presented At The American Society Of Clinical Oncology Annual Meeting (ASCO 2015)

The 51st annual meeting of the American Society of Clinical Oncology (ASCO) started earlier to­day, May 29, and will go through June 2 in Chicago.

Approximately 30,000 physicians and re­searchers from all over the world are ex­pec­ted to attend the five-day meeting to discuss cur­rent re­search in cancer treat­ment and care.

During the meeting, there will be pre­sen­ta­tions about all types of cancer, in­clud­ing many pre­sen­ta­tions focused spe­cif­i­cally on mul­ti­ple myeloma. In fact, more than 90 myeloma-related stud­ies are scheduled to be pre­sented, in one form or another, in con­nec­tion with the …

Read the full story »

Opinion»

[ by | Apr 4, 2015 5:06 am | 60 Comments ]
Pat’s Place:  Decision Made - I’m Going To Transplant Again

I’m fond of saying, “I still have a number of myeloma ther­a­py op­tions, but none of them are good.” The last part is a re­flec­tion of in­vesti­ga­tional work I’ve done speaking with a number of myeloma experts I know.

For two months, I’ve promised to share which direction my lovely wife, Pattie, and I have decided to go in terms of my next treat­ment. After six months of pros and cons lists, con­ver­sa­tions with readers, family, friends, and other myeloma sur­vivors, we’ve made a decision. We were em­bold­ened after shift­ing through piles of therapy and …

Read the full story »

News»

[ by and | Mar 23, 2015 5:27 pm | 10 Comments ]
Additional Treatment To Deepen Response Prior To Transplantation May Not Improve Survival In Newly Diagnosed Multiple Myeloma

A recently published study may change the goals many myeloma special­ists use to make treatment decisions for newly diagnosed myeloma pa­tients planning on having a stem cell transplant.

The study also has potentially broader implications. Indeed, it may influ­ence ongoing debate on a fundamental controversy about how multiple myeloma, in general, should be treated.

The authors of the new study looked at data for 539 myeloma patients who failed to achieve even a partial response to their initial (induction) treat­ment regimen after diagnosis.

After their initial treatment failed, some of the 539 patients …

Read the full story »

Opinion»

[ by | Jan 22, 2015 3:13 pm | 27 Comments ]
Mohr’s Myeloma Musings: Using Common Sense After A Stem Cell Transplant

In many of my previous columns, I have stipulated that I am very fortunate with what I have experienced so far with multiple myeloma.

My condition is far less serious than that of most of the other Beacon columnists and probably the vast majority of my readers. Every form of treatment I have re­ceived so far – radiation, induction therapy, and autol­o­gous stem cell trans­plan­ta­tion – has been suc­cess­ful. Modern medicine had done its part for me.

Unfortunately, I have come to the conclusion that I have not done my part to …

Read the full story »

News»

[ by | Dec 10, 2014 3:12 pm | 3 Comments ]
ASH 2014 Multiple Myeloma Update - Day Two: Education Session And Midday Oral Session

This past Sunday was the second day of the American Society of Hema­tology’s (ASH) annual meeting, which was held in San Francisco.

As on the first day of the meeting, myeloma-related pre­sen­ta­tions once again took place during several sessions through­out the day.

A myeloma-related education session held the first day of the conference was repeated once again on Sunday morning.

While the education session was being held, a separate “scientific sym­po­sium” with two oral pre­sen­ta­tions took place in parallel.  The session focused on a novel immuno­therapeutic ap­proach to treating cancer known as …

Read the full story »

News»

[ by | Dec 7, 2014 9:07 am | 3 Comments ]
ASH 2014 Multiple Myeloma Update - Day One: Oral Sessions

This year’s meeting of the American Society of Hematology (ASH) began yesterday morning in San Francisco.

Myeloma-related presentations were made during several sessions throughout the day.

The day started out with a session designed to better educate physicians about multiple myeloma and how to treat the disease.

Two sessions of oral presentations devoted solely to multiple myeloma ran simultaneously in the middle of the day. One of the sessions focused on the biology of the disease. The other one included presentations on new myeloma ther­a­pies for both newly diagnosed and re­lapsed and …

Read the full story »